Acurx Pharmaceuticals, Inc. — Director's Dealing 2021

Sep 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Acurx Pharmaceuticals, Inc. (ACXP)
CIK: 0001736243
Period of Report: 2021-06-29

Reporting Person: Sailer Carl (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-29	Common Stock	P	12500	$6.00	Acquired	67917	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Indirect

Footnotes

F1: Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the "Issuer") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share.